TP53 and lung carcinoma: Demetrio Raffa et al., (2019) studied a series of Pyrazole derivatives on a human lung carcinoma cell line and they revealed the apoptotic cell death by activating TRAIL death receptors followed by caspase-8 activation (extrinsic pathway) or changes in p53 activation (intrinsic pathway).